Related Experiment Video
Updated: Aug 4, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus
1The Rockefeller University, New York, New York 10021, USA.
Abstract:
In five vancomycin-resistant laboratory step mutants selected from the highly and homogeneously methicillin-resistant Staphylococcus aureus strain COL (MIC of methicillin, 800 microg/ml; MIC of vancomycin, 1.5 microg/ml), the gradually increasing levels of resistance to vancomycin were accompanied by parallel decreases in the levels of methicillin resistance and abnormalities in cell wall metabolism. The latter included a gradual reduction in the proportion of highly cross-linked muropeptide species in peptidoglycan, down-regulation of the production of penicillin-binding protein 2A (PBP2A) and PBP4, and hypersensitivity to beta-lactam antibiotics each with a relatively selective affinity for the various staphylococcal PBPs; the PBP2-specific inhibitor ceftizoxime was particularly effective.
Insights
Laboratory-induced vancomycin resistance in Staphylococcus aureus led to decreased methicillin resistance and altered cell wall metabolism. This suggests a trade-off between resistance mechanisms and impacts bacterial cell integrity.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
- Vancomycin is a critical antibiotic for treating MRSA infections.
- Emergence of vancomycin resistance in MRSA necessitates understanding resistance mechanisms.
Purpose of the Study:
- To investigate the relationship between vancomycin resistance and methicillin resistance in Staphylococcus aureus.
- To characterize the associated changes in cell wall metabolism during the development of vancomycin resistance.
Main Methods:
- Selection of vancomycin-resistant laboratory step mutants from a highly methicillin-resistant S. aureus strain (COL).
- Analysis of cell wall metabolism, including peptidoglycan cross-linking and penicillin-binding protein (PBP) production.
- Assessment of susceptibility to beta-lactam antibiotics.
Main Results:
- Increasing vancomycin resistance correlated with decreasing methicillin resistance.
- Observed abnormalities in cell wall metabolism, including reduced peptidoglycan cross-linking.
- Down-regulation of penicillin-binding protein 2A (PBP2A) and PBP4 production was noted.
- Mutants exhibited hypersensitivity to beta-lactam antibiotics, with ceftizoxime (a PBP2 inhibitor) being particularly effective.
Conclusions:
- Vancomycin resistance acquisition in MRSA may involve a trade-off with methicillin resistance.
- Alterations in cell wall metabolism and PBP expression are associated with vancomycin resistance.
- Targeting specific PBPs, like PBP2, could be a therapeutic strategy against vancomycin-resistant MRSA.
More Related Videos
Related Concept Videos
Bacterial Cell Wall
Development of Antibiotic Resistance
Archaeal Cell Wall
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance

